arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 1908.06340stat.AP
收藏

20年来临床试验中COPD加重的下降--一项系统性综述和荟萃回归

Decline of COPD exacerbations in clinical trials over two decades -- a systematic review and meta-regression

Stefan Andreas, Christian Röver, Judith Heinz, Sebastian Straube, Henrik Watz, Tim Friede

摘要:

背景:慢性阻塞性肺疾病(COPD)治疗的一个重要目标是减少加重的频率。一些观察结果表明,临床试验中急性加重率随时间推移而下降。更系统的理解将有助于改善COPD试验的设计和解释。方法:我们对已发表的以急性加重为结局的随机对照试验中的安慰剂组进行了系统回顾和荟萃回归。开发了贝叶斯负二项模型,以适应以不同格式报告的结果;结果以可信区间(CI)和后验尾概率($p_B$)报告。结果:在我们检索到的1114项研究中,最终纳入了55项。加重率每年下降6.7%(95% CI(4.4,9.0); $p_B$ < 0.001),或每10年下降50%(95% CI(36,61))。调整现有的研究和基线特征,如1秒用力呼气量(FEV 1)并没有明显改变观察到的趋势。两个亚组的研究,一个使用真正的安慰剂组,另一个允许吸入皮质类固醇的“安慰剂”组,也产生了一致的结果。结论:总之,该荟萃回归表明,在过去20年中,COPD急性加重的发生率降低至临床相关程度,与重要的预后因素无关。这表明,在设计新的试验或将旧试验的结果与最近的试验进行比较时需要谨慎。此外,可以假设辅助治疗对COPD急性加重有相当大的影响。

英文摘要:

BACKGROUND: An important goal of chronic obstructive pulmonary disease (COPD) treatment is to reduce the frequency of exacerbations. Some observations suggest a decline in exacerbation rates in clinical trials over time. A more systematic understanding would help to improve the design and interpretation of COPD trials. METHODS: We performed a systematic review and meta-regression of the placebo groups in published randomized controlled trials reporting exacerbations as an outcome. A Bayesian negative binomial model was developed to accommodate results that are reported in different formats; results are reported with credible intervals (CI) and posterior tail probabilities ($p_B$). RESULTS: Of 1114 studies identified by our search, 55 were ultimately included. Exacerbation rates decreased by 6.7% (95% CI (4.4, 9.0); $p_B$ < 0.001) per year, or 50% (95% CI (36, 61)) per decade. Adjusting for available study and baseline characteristics such as forced expiratory volume in 1 s (FEV1) did not alter the observed trend considerably. Two subsets of studies, one using a true placebo group and the other allowing inhaled corticosteroids in the "placebo" group, also yielded consistent results. CONCLUSIONS: In conclusion, this meta-regression indicates that the rate of COPD exacerbations decreased over the past two decades to a clinically relevant extent independent of important prognostic factors. This suggests that care is needed in the design of new trials or when comparing results from older trials with more recent ones. Also a considerable effect of adjunct therapy on COPD exacerbations can be assumed.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑